PL2555789T3 - Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania - Google Patents

Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania

Info

Publication number
PL2555789T3
PL2555789T3 PL11718957T PL11718957T PL2555789T3 PL 2555789 T3 PL2555789 T3 PL 2555789T3 PL 11718957 T PL11718957 T PL 11718957T PL 11718957 T PL11718957 T PL 11718957T PL 2555789 T3 PL2555789 T3 PL 2555789T3
Authority
PL
Poland
Prior art keywords
trem
tlt
transcript
peptides derived
inhibiting peptides
Prior art date
Application number
PL11718957T
Other languages
English (en)
Inventor
Sébastien GIBOT
Marc Derive
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Université De Lorraine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Université De Lorraine filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Publication of PL2555789T3 publication Critical patent/PL2555789T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11718957T 2010-04-08 2011-04-08 Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania PL2555789T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10305364 2010-04-08
EP11718957.1A EP2555789B1 (en) 2010-04-08 2011-04-08 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
PCT/EP2011/055519 WO2011124685A1 (en) 2010-04-08 2011-04-08 Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof

Publications (1)

Publication Number Publication Date
PL2555789T3 true PL2555789T3 (pl) 2021-02-08

Family

ID=42262363

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11718957T PL2555789T3 (pl) 2010-04-08 2011-04-08 Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania

Country Status (19)

Country Link
US (2) US9255136B2 (pl)
EP (2) EP2555789B1 (pl)
JP (2) JP5918750B2 (pl)
CN (1) CN103153327B (pl)
AU (1) AU2011237851B2 (pl)
CA (1) CA2795390C (pl)
CY (1) CY1123304T1 (pl)
DK (1) DK2555789T3 (pl)
ES (1) ES2805301T3 (pl)
HR (1) HRP20201081T1 (pl)
HU (1) HUE050815T2 (pl)
LT (1) LT2555789T (pl)
NZ (1) NZ602845A (pl)
PL (1) PL2555789T3 (pl)
PT (1) PT2555789T (pl)
RS (1) RS60636B1 (pl)
SI (1) SI2555789T1 (pl)
SM (1) SMT202000407T1 (pl)
WO (1) WO2011124685A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12419839B2 (en) 2009-10-09 2025-09-23 Signablok, Inc. Methods and compositions for targeted delivery of protein fragments
AU2013311606B2 (en) * 2012-09-07 2017-10-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) Trem-Like Transcript 1 (TLT-1) and uses thereof
KR101404098B1 (ko) * 2012-11-29 2014-06-05 성균관대학교산학협력단 금속 나노와이어-유기화합물 복합체, 이를 포함하는 필름, 및 이의 제조 방법
AU2016274175B2 (en) 2015-06-12 2021-02-18 Mackay Medical Foundation The Presbyterian Church In Taiwan Mackay Memorial Hospital Methods and polypeptides for modulation of immunoresponse
JOP20190248A1 (ar) 2017-04-21 2019-10-20 Amgen Inc بروتينات ربط مولد ضد trem2 واستخداماته
CN108276488B (zh) * 2018-01-26 2020-06-19 四川农业大学 一种鸡髓样细胞触发受体b2多克隆抗体及其制备方法和应用
WO2020036987A1 (en) 2018-08-13 2020-02-20 Signablok, Inc. Peptides and compositions for targeted treatment and imaging
US20210364532A1 (en) * 2018-09-28 2021-11-25 Inotrem Use of soluble trem-1 levels for identifying subjects susceptible to respond to an anti-inflammatory therapy
PH12021552586A1 (en) 2019-04-17 2023-07-31 Novo Nordisk As Bispecific antibodies
WO2021144388A1 (en) 2020-01-15 2021-07-22 Fresenius Kabi Ipsum S.R.L. Process for the synthesis of nangibotide
US20230330222A1 (en) * 2020-05-14 2023-10-19 Ascendo Biotechnology, Inc. Selective targeting of the treml1/md2 interaction by small peptide or protein and its use for vaccine adjuvants
JP2023529089A (ja) * 2020-06-05 2023-07-07 イノトレム コロナウイルス感染症に罹患した対象の治療に使用するためのｔｒｅｍ－１阻害剤
CA3220167A1 (en) 2021-06-02 2022-12-08 Marc Derive Anti-trem-1 antibodies
CN113755580B (zh) * 2021-09-13 2023-10-27 中国医学科学院阜外医院 一种治疗和/或缓解淋巴水肿的药物干预靶点及其应用
WO2024153243A1 (zh) * 2023-01-19 2024-07-25 武汉人福创新药物研发中心有限公司 作为Trem-1抑制剂的修饰肽

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2005261A (en) 1933-05-24 1935-06-18 Leland Electric Co Riveting machine
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
ES2259800T3 (es) 1990-06-11 2006-10-16 Gilead Sciences, Inc. Procedimientos de uso de ligandos de acido nucleico.
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
DE69434860T2 (de) 1993-02-22 2007-03-15 The Rockefeller University Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US7129072B1 (en) 1999-08-30 2006-10-31 New York University Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor
AU4705201A (en) 1999-10-27 2001-06-25 Cel-Sci Corporation Peptide constructs for treating autoimmune and related diseases
JP2001210726A (ja) * 2000-01-24 2001-08-03 Hitachi Ltd 半導体装置及びその製造方法
DE60118362T2 (de) * 2000-05-19 2007-05-24 The Center for Blood Research, Inc., Boston VERFAHREN ZUR BEHANDLUNG VON HÄMOSTATISCHEN STÖRUNGEN DURCH LöSLICHES P-SELECTIN
AU2001274947B2 (en) * 2000-05-23 2006-08-17 Acorda Therapeutics, Inc. Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US20040266674A1 (en) * 2001-09-05 2004-12-30 Mills Bradley Jay Lp mammalian proteins; related reagents
US20040180409A1 (en) * 2003-03-16 2004-09-16 Mcvicar Daniel TLT-1, a novel platelet-associated receptor and uses therefor
GB0426146D0 (en) * 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
US20130332133A1 (en) 2006-05-11 2013-12-12 Ramot At Tel Aviv University Ltd. Classification of Protein Sequences and Uses of Classified Proteins
US7553936B2 (en) * 2006-12-04 2009-06-30 The United States of America as represented by Secretary Department of Health and Human Services Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
WO2010132370A2 (en) * 2009-05-11 2010-11-18 Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Soluble tlt-1 for the treatment and diagnosis of sepsis

Also Published As

Publication number Publication date
CY1123304T1 (el) 2021-12-31
PT2555789T (pt) 2020-07-14
HUE050815T2 (hu) 2021-01-28
CA2795390C (en) 2020-11-03
EP2555789A1 (en) 2013-02-13
SI2555789T1 (sl) 2020-10-30
DK2555789T3 (da) 2020-07-20
NZ602845A (en) 2015-05-29
AU2011237851B2 (en) 2015-02-05
US9815883B2 (en) 2017-11-14
ES2805301T3 (es) 2021-02-11
LT2555789T (lt) 2020-09-25
EP2555789B1 (en) 2020-06-10
EP3741383A1 (en) 2020-11-25
AU2011237851A1 (en) 2012-11-01
JP2016169208A (ja) 2016-09-23
CN103153327A (zh) 2013-06-12
CN103153327B (zh) 2016-01-20
US20130029921A1 (en) 2013-01-31
JP2013523140A (ja) 2013-06-17
JP5918750B2 (ja) 2016-05-18
WO2011124685A1 (en) 2011-10-13
US9255136B2 (en) 2016-02-09
HRP20201081T1 (hr) 2021-01-22
SMT202000407T1 (it) 2020-09-10
RS60636B1 (sr) 2020-09-30
CA2795390A1 (en) 2011-10-13
US20160015773A1 (en) 2016-01-21

Similar Documents

Publication Publication Date Title
PL2555789T3 (pl) Peptydy hamujące pochodzące z transkryptu trem-podobnego 1 (tlt-1) i ich zastosowania
IL219882A0 (en) System for increasing gene expression and vector comprising the system
GB0914110D0 (en) Peptide libraries
PT3536333T (pt) Sistema de depósito compreendendo acetato de glatirâmero
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
IL248880A0 (en) Preparations containing r-g-cysteic acid peptides and their uses
EP2593595A4 (en) NOVEL PEPTIDES AND USES THEREOF
EP2521564A4 (en) APOE PEPTIDE DIMERS AND USES THEREOF
HUE039735T2 (hu) Rekombináns-CDV-készítmények és alkalmazásaik
PL2627668T3 (pl) Peptydy i ich zastosowanie
EP2471553A4 (en) IMMUNOGENIC COMPOSITION WITH PEPTIDES FROM CYTOMEGALOVIRUS AND THEIR USE
PL2464656T3 (pl) Nowy peptyd i jego zastosowanie
PL3346273T3 (pl) Nowe, pochodzące od d3 d-enancjomeryczne peptydy i ich zastosowanie
IL216199A (en) A peptide containing the sequence ednimvtfrnqasr
IL213026A0 (en) TNA-a INHIBITING PEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
IL225464A0 (en) 2nd peptides, preparations containing them and their uses
SG173752A1 (en) Modifications of cupredoxin derived peptides and methods of use thereof
IL225405A0 (en) Methods for immune modulation and systems for the treatment and/or prevention of atherosclerosis, proteins, peptides and preparations.
ZA201203722B (en) Peptide
GB2489887B (en) Cover for a laparoscope, systems including the cover and methods of use
WO2011087491A9 (en) Parstatin peptides and uses thereof
TWI369211B (en) An isolated peptide and the preparation processes and applications thereof
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
EP2415780A4 (en) SYNTHETIC PEPTIDE AND USES THEREOF
GB0816561D0 (en) Peptides and uses thereof